T1	disease_or_phenotypic_feature 0 20	infection-associated
T2	disease_or_phenotypic_feature 44 69	obstructive hydrocephalus
T3	chemical 125 133	residual
T4	missed_chemical 173 190	Dietary compounds
T5	disease_or_phenotypic_feature 221 236	atherosclerosis
T6	chemical 262 273	cholesterol
T7	missed_disease_or_phenotypic_feature 289 301	inflammation
T8	chemical 515 530	steroid-induced
T9	disease_or_phenotypic_feature 515 539	steroid-induced glaucoma
T10	disease_or_phenotypic_feature 568 595	vernal keratoconjunctivitis
T11	chemical 709 715	toxins
T12	disease_or_phenotypic_feature 740 757	colorectal cancer
T13	chemical 933 940	glucose
T14	chemical 945 950	lipid
T15	disease_or_phenotypic_feature 1020 1028	diseases
T16	disease_or_phenotypic_feature 1211 1220	infection
T18	chemical 1255 1270	polysaccharides
T20	chemical 1432 1441	inhibitor
T21	disease_or_phenotypic_feature 1480 1490	dependence
T22	disease_or_phenotypic_feature 1596 1601	blood
T23	disease_or_phenotypic_feature 1634 1639	blood
T24	chemical 1696 1701	lipid
T25	chemical 1761 1776	phosphorylation
T26	chemical 1829 1844	phosphorylation
T27	chemical 2034 2048	phosphorylated
T28	chemical 2049 2057	residues
T29	disease_or_phenotypic_feature 2082 2086	rich
T30	chemical 2097 2105	residues
T31	chemical 2324 2328	drug
T32	disease_or_phenotypic_feature 2376 2394	Takayasu arteritis
T33	disease_or_phenotypic_feature 2443 2446	ITP
T34	chemical 2465 2497	thrombopoietin receptor agonists
T35	chemical 2480 2497	receptor agonists
T36	missed_chemical 2499 2506	TPO-RAs
T37	chemical 2523 2534	eltrombopag
T38	chemical 2633 2644	methylation
T39	disease_or_phenotypic_feature 2692 2704	cleft palate
T40	chemical 2784 2800	sodium hydroxide
T41	disease_or_phenotypic_feature 2818 2831	osteoporosis]
T42	chemical 2931 2934	ion
T43	disease_or_phenotypic_feature 2931 2934	ion
T44	chemical 2967 2977	Naringin-G
T45	disease_or_phenotypic_feature 3024 3027	SDS
T46	chemical 3152 3159	alcohol
T47	disease_or_phenotypic_feature 3164 3173	disorders
T48	corrected_chemical 3391 3432	Specialized Pro-resolving Lipid Mediators
T49	chemical 3403 3416	Pro-resolving
T50	chemical 3417 3422	Lipid
T51	missed_disease_or_phenotypic_feature 3454 3466	Inflammation
T52	disease_or_phenotypic_feature 3470 3485	Cystic Fibrosis
T53	chemical 3523 3531	glucagon
T54	disease_or_phenotypic_feature 3544 3547	fed
T55	disease_or_phenotypic_feature 3661 3687	small bowel adenocarcinoma
T56	chemical 3782 3801	glucose-transporter
T57	chemical 3904 3907	TTP
T58	disease_or_phenotypic_feature 3904 3907	TTP
T59	disease_or_phenotypic_feature 3950 3957	obesity
T60	chemical 3962 3965	NoP
T61	disease_or_phenotypic_feature 3976 3983	obesity
T62	disease_or_phenotypic_feature 4054 4061	obesity
R1	treats Arg1:T48 Arg2:T51
R2	treats Arg1:T48 Arg2:T52
R3	treats Arg1:T31 Arg2:T32
R4	treats Arg1:T37 Arg2:T33
R6	treats Arg1:T36 Arg2:T33
R7	treats Arg1:T4 Arg2:T5
R8	treats Arg1:T4 Arg2:T7
R9	treats Arg1:T34 Arg2:T33
T63	missed_disease_or_phenotypic_feature 597 600	VKC
T64	corrected_chemical 515 522	steroid
R11	causes_or_contributes_to Arg1:T64 Arg2:T17	
R12	treats Arg1:T64 Arg2:T10	
R13	treats Arg1:T64 Arg2:T63	
T17	corrected_disease_or_phenotypic_feature 531 539	glaucoma
T19	missed_chemical 2508 2519	romiplostim
R5	treats Arg1:T19 Arg2:T33	
T65	missed_chemical 2537 2546	rituximab
R10	treats Arg1:T65 Arg2:T33	
T66	missed_disease_or_phenotypic_feature 3160 3173	use disorders
R14	causes_or_contributes_to Arg1:T46 Arg2:T66	
T67	missed_disease_or_phenotypic_feature 3175 3179	AUDs
R15	causes_or_contributes_to Arg1:T46 Arg2:T67	
T68	missed_disease_or_phenotypic_feature 3604 3618	lower glycemia
R16	causes_or_contributes_to Arg1:T53 Arg2:T68	
